Related Experiment Video
Updated: May 1, 2026

13:04
In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
12.8K
Incessant ovulation and ovarian cancer - a hypothesis re-visited
1Professor of Obstetrics and Gynaecology, Assiut University, Egypt, P.O.30, Assiut, Egypt.
Facts, Views & Vision in Obgyn
|April 23, 2014
Summary
Preventing ovarian cancer may involve strategies targeting ovulation. Research explores oral contraceptives, non-hormonal ovulation suppression, and Fallopian tube interventions for early cancer prevention.
Area of Science:
- Gynecology
- Oncology
- Reproductive Biology
Background:
- Ovarian cancer is often diagnosed at advanced stages, necessitating effective prevention strategies.
- The hypothesis linking incessant ovulation to epithelial ovarian cancer development has spurred research.
- Current screening methods for ovarian cancer have limited success.
Purpose of the Study:
- To review and highlight potential prevention strategies for epithelial ovarian cancer.
- To explore the role of ovulation in ovarian cancer development and prevention.
- To identify opportunities for both general population and high-risk group interventions.
Main Methods:
- Review of existing research on ovulation and ovarian cancer.
- Analysis of the protective effects of oral contraceptive pills.
- Exploration of novel preventive interventions targeting ovulation and Fallopian tube origins.
Main Results:
- Oral contraceptive pills demonstrate a documented protective effect against ovarian cancer.
- Expanding access to contraception can increase population-level protection.
- Understanding ovulation mechanisms may lead to non-hormonal pharmacologic suppression of follicle rupture.
- Salpingectomy during hysterectomy offers a potential preventive measure for Fallopian tube cancers.
- The egg-laying hen model shows promise for chemoprevention studies.
Conclusions:
- Revisiting prevention strategies, particularly those related to ovulation, is crucial for combating ovarian cancer.
- Interventions like oral contraceptives, non-hormonal ovulation suppression, and Fallopian tube surgery can significantly reduce ovarian cancer incidence.
- Further research into the biological mechanisms of ovulation and cancer origins can yield innovative preventive therapies.
Related Concept Videos
Oogenesis
58.4K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
58.4K
Oogenesis
5.0K
Oogenesis, the process of developing egg cells (female gametes), occurs within the ovaries and is fundamental to female fertility. This sequence begins during fetal development when diploid oogonia in the developing ovaries undergo mitotic divisions to produce primary oocytes. By birth, these primary oocytes enter prophase I of meiosis but become arrested in this stage, remaining suspended until puberty.
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is...
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is...
5.0K
Ovarian Cycle
5.4K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
5.4K
Hormonal Control of the Ovarian Cycle
5.1K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
5.1K
Nondisjunction
4.5K
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
4.5K
Infertility in Females
4.8K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
4.8K

